CorTec receives FDA ‘breakthrough’ designation for brain-computer interface in stroke rehabilitation
CorTec has received “Breakthrough Device Designation” from the US Food and Drug Administration for its Brain Interchange system, a fully implantable brain-computer interface (BCI) designed to support motor recovery in stroke patients. The designation applies to the use of direct cortical electrical stimulation to treat chronic stroke-related impairments, marking what the company describes as the […]
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.